TU
The University of Chicago Innovation Fund
Venture CapitalModerateUChicagoTech launched the Innovation Fund in 2010 to accelerate the commercialization of promising.
8
Investments
6
Exits
null
AUM
75.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for The University of Chicago Innovation Fund.
Investment Thesis & Strategy
The University of Chicago Innovation Fund invests in various stages of companies across a broad range of industries, with a focus on accelerating the commercialization of promising technologies and innovations.
Investment Activity
Deals per year over the last 8 years
1
20153
20162
20172
20181
20190
20202
20211
2022Portfolio Companies
Selected investments from their portfolio of 8 companies
P
Project InnerSpace
Healthcare · Series A, 2022
B
Brimstone
Cleantech · Series A, 2021
C
ClostraBio
Biotech · Series A, 2021
T
Tyra Biosciences
Biotech · Series A, 2019
V
VentureLab
Other · Series A, 2018
E
Endeavor BioMedicines
Biotech · Series A, 2018
T
Tovala
Food & Beverage · Series A, 2017
N
Navenio
Healthcare · Series A, 2017
R
Rheaply
Other · Series A, 2016
P
Parachute Health
Healthcare · Series A, 2016
E
ExplORer Surgical
Healthcare · Series A, 2016
T
Tempus
Healthcare · Series A, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
TempusIPO2024$6.1B
TovalaAcquisition2024—
Endeavor BioMedicinesIPO2024—
ExplORer SurgicalAcquisition2023—
ClostraBioAcquisition2023—
Tyra BiosciencesIPO2022$600M
Frequently Asked Questions
The University of Chicago Innovation Fund focuses on Series A, Series B, Series C+ stage investments.
Related Investors
ARCH Venture Partners
Chicago, United States · 340 deals
Pritzker Group Venture Capital
Chicago, United States · 210 deals
Lightbank
Chicago, United States · 150 deals
Chicago Ventures
Chicago, United States · 135 deals
Hyde Park Venture Partners
Chicago, United States · 131 deals
Second Century Ventures
Chicago, United States · 128 deals